Cancel
Known information
- Joined Oncocyte Corporation in August 2020
- Appointed Interim Chief Executive Officer in December 2022
- Previously served as Senior Director Business Development and General Manager, Transplant
- Was the founder and principal of Intelliger Consulting, focused on consumer driven healthcare
- Served as a principal at Bethesda Group, LLC, helping small and mid-stage diagnostic companies and investment groups move emerging diagnostic content and platforms to market
About OncoCyte
OncoCyte specializes in oncology and transplant diagnostic solutions, offering products like DetermaCNI, DetermaIO, VitaGraft Kidney, and VitaGraft Liver, alongside biopharma services to enhance patient care.
Report inaccurate information
